Susquehanna International Group, LLP Sellas Life Sciences Group, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,489,672 shares of SLS stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,489,672
Previous 688,696
116.3%
Holding current value
$2.5 Million
Previous $743,000
339.03%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SLS
# of Institutions
84Shares Held
22.6MCall Options Held
1.3MPut Options Held
59.3K-
Vanguard Group Inc Valley Forge, PA6.65MShares$11.2 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.72MShares$4.56 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.13MShares$1.89 Million0.0% of portfolio
-
State Street Corp Boston, MA1.11MShares$1.87 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $34.5M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...